The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback